Interventions to Reduce Shoulder MSDs in Overhead Assembly

ICR 201511-0920-009

OMB: 0920-0964

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Modified
Form
Modified
Form
Modified
Form
Modified
Form
Modified
Form
Modified
Form
Modified
Supplementary Document
2015-11-18
Supplementary Document
2015-11-18
Supplementary Document
2015-11-18
Supplementary Document
2015-11-18
Supplementary Document
2015-11-17
Supplementary Document
2015-11-17
Supplementary Document
2015-11-17
Supporting Statement B
2015-11-17
Supporting Statement A
2015-11-17
Supplementary Document
2013-01-15
ICR Details
0920-0964 201511-0920-009
Historical Active 201302-0920-015
HHS/CDC 18524
Interventions to Reduce Shoulder MSDs in Overhead Assembly
Reinstatement without change of a previously approved collection   No
Regular
Approved without change 03/04/2016
Retrieve Notice of Action (NOA) 11/24/2015
  Inventory as of this Action Requested Previously Approved
03/31/2018 24 Months From Approved
2,268 0 0
238 0 0
0 0 0

CDC request approval for completion of this study, conducted in partnership with Toyota Motor Manufacturing Kentucky, Inc., which will evaluate the efficacy of two intervention strategies for reducing musculoskeletal symptoms and pain in the shoulder attributable to overhead assembly work in automotive manufacturing.

PL: Pub.L. 91 - 596 20-22 Name of Law: Occupational Safety and Health Act of 1970
  
None

Not associated with rulemaking

  80 FR 32131 06/05/2015
80 FR 7108 11/17/2015
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 2,268 0 0 2,268 0 0
Annual Time Burden (Hours) 238 0 0 238 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a reinstatement without change. Additional time is needed to complete the study. There is a reduction in the original number of respondents and burden hours as the study was not completed during the previous approval period,

$86,520
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Carol Marsh 404 639-4773 cww6@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/24/2015


© 2024 OMB.report | Privacy Policy